Search
Tempest Therapeutics Inc
TPSTAdd to Watchlist
0.496USD
-0.037-6.94%
Close 10-30 16:00（ET）
8.38MMarket Cap
0.02P/E TTM
After-hours 16:33 (ET)0.502USD-0.002-0.40%
After-hours 16:33 (ET)Tempest Therapeutics Inc (TPST) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to Tempest Therapeutics Inc in the past month.
Buy
0 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
7.000USD+1196.54%
TPST Analyst Recommendation Trends
In the current month, TPST has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. TPST average Analyst price target in the last month is 7.000.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
TPST Analyst Rating for Peer Comparison
Updated: Nov 1, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
14
3
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Insmed Inc
INSM
7
18
0
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Kymera Therapeutics Inc
KYMR
9
13
2
0
0
24
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Biontech SE
BNTX
4
11
8
0
0
23
IQVIA Holdings Inc
IQV
8
12
3
0
0
23
Financial Forecasting
Based on analysts' estimates, TPST EPS is projected to reach -0.320 in FY2026Q3, following reported EPS of -0.344 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.62
-0.28
-0.30
-0.32
-0.29
Actual
-0.82
-2.53
-0.34
--
--
Surprise
-32.16%
-804.85%
-14.82%
--
--
FAQs
What is Tempest Therapeutics Inc's price target?
Analysts forecast that Tempest Therapeutics Inc's price target is USD 7.00, with the highest forecast at USD 7.00 and the lowest forecast at USD 7.00.
How have Tempest Therapeutics IncTPST's recent earnings per share performed?
The market expectation was USD -0.34, while Tempest Therapeutics IncTPST's earnings per share (EPS) for the previous quarter was USD -2.53. EPS for the next quarter is expected at USD -0.32.
What is the analyst rating for Tempest Therapeutics Inc?
Based on the ratings of Tempest Therapeutics Inc's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.